Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study

OBJECTIVE: Patients with chronic hepatitis B (CHB) are reported to exhibit higher risk of subsequent hepatocellular carcinoma (HCC). However, it remains unclear if Chinese herbal medicine (CHM), an important category of traditional Chinese medicine (TCM), may lower HCC risk in this population. So th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Tzung-Yi, Livneh, Hanoch, Hung, Tsung-Hsing, Lin, I -Hsin, Lu, Ming-Chi, Yeh, Chia-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278254/
https://www.ncbi.nlm.nih.gov/pubmed/28122837
http://dx.doi.org/10.1136/bmjopen-2016-014571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278254/
https://www.ncbi.nlm.nih.gov/pubmed/28122837
http://dx.doi.org/10.1136/bmjopen-2016-014571

Ejemplares similares